Prof Jan C. Grutters MD, PhD, is a pulmonary physician at the St. Antonius Hospital Nieuwegein and University Medical Center Utrecht, and professor of Interstitial Lung Diseases. He is head of Pulmonology Department at St. Antonius Hospital, and participating member of the Lung Transplant Team Utrecht/Nieuwegein. In 2001 he was awarded an ERS Research Fellowship at the Imperial College and Brompton Hospital London, resulting in the Thesis: ‘Genetic polymorphisms and phenotypes in sarcoidosis’. Jan Grutters is a member of the Editorial Board of WASOG, of the medical advisory board of the Dutch Sarcoidosis Society, as well as the Dutch Pulmonary Fibrosis Society, and Worldwide LAM Patient Coalition. He supervises research into sarcoidosis and pulmonary fibrosis, with special focus on biomarkers and the genetic predisposition of ILD.
Dr. Coline van Moorsel is Head Research Interstitial Lung Disease at St Antonius Hospital Nieuwegein and University Utrecht in The Netherlands. She received her MSc degree in Biology cum laude from Leiden University. Her PhD-studies on genetic diversification were performed in collaboration with Wageningen University and the National Museum of Natural History and she received her PhD degree in molecular genetics from Leiden University. As a postdoctoral researcher she joined the Central Laboratory of Blood Transfusion services to develop human mutation detection arrays for hereditary anaemia and bloodgroup typing in collaboration with Amsterdam Medical Center and Clinical Genetics Center Leiden. As a senior scientist she joined the Clinical Chemistry Laboratory of St Antonius Hospital to investigate genetic causes of pulmonary diseases and later joined the Pulmonology department of St Antonius Hospital and Utrecht University Medical Center to investigate biological factors that influence disease development and susceptibility to Interstitial Lung Diseases. She is currently head of the Researchgroup Interstitial Lung Disease where she conducts and supervises research on genetic factors and biomarkers in ILD and lung transplantation.